Prognostic Factors in Older Patients with Advanced Non-small Cell Lung Cancer in China-Reference-Cited by-同舟云学术

Prognostic Factors in Older Patients with Advanced Non-small Cell Lung Cancer in China

Published:2014-01 Issue:1 Volume:100 Page:69-74
ISSN:0300-8916
Container-title:Tumori Journal
language:en
Short-container-title:Tumori Journal

Author:

Su Qiang¹,Sun Yu-Ping²,Liu Ye-Hui²,Li Zhe³,Yang Hong-Yan²,Sun Zhi-Gang³,Cao Bang-Wei¹,Jia Ji-Hui⁴

Affiliation:

1. Department of Medical Oncology, Beijing Friendship Hospital, Capital Medical University, Beijing

2. Department of Oncology, Jinan Center Hospital Affiliated to Shandong University, Shandong University, Jinan

3. Department of Examination Center, Jinan Center Hospital Affiliated to Shandong University, Shandong University, Jinan

4. Department of Thoracic Surgery, Qianfoshan Hospital Affiliated to Shandong University, Jinan Center Hospital Affiliated to Shandong University, Shandong University, Jinan

Publisher

SAGE Publications

Subject

Cancer Research,Oncology,General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/1430.15818

Reference30 articles.

1. Cancer Statistics, 2009

2. The Role of the Taxanes in the Treatment of Older Patients with Advanced Stage Non-Small Cell Lung Cancer

3. Non-Small Cell Lung Cancer Guidelines

4. The international system for staging lung cancer

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk Factors for Thyroid Dysfunction in Patients with Advanced Non-Small-Cell Lung Cancer Treated with PD-1 Antibody;Evidence-Based Complementary and Alternative Medicine;2022-08-12

2. A risk model to predict 2-year survival after VATS lobectomy for non-small-cell lung cancer;European Journal of Cardio-Thoracic Surgery;2019-11-13

3. Single pemetrexed is noninferior to platinum-based pemetrexed doublet as first-line treatment on elderly Chinese patients with advanced nonsquamous nonsmall cell lung cancer;Medicine;2017-03